Mark Holdbrook

1.1k total citations
28 papers, 909 citations indexed

About

Mark Holdbrook is a scholar working on Public Health, Environmental and Occupational Health, Dermatology and Ophthalmology. According to data from OpenAlex, Mark Holdbrook has authored 28 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 13 papers in Dermatology and 5 papers in Ophthalmology. Recurrent topics in Mark Holdbrook's work include Ocular Surface and Contact Lens (13 papers), Acne and Rosacea Treatments and Effects (12 papers) and Contact Dermatitis and Allergies (6 papers). Mark Holdbrook is often cited by papers focused on Ocular Surface and Contact Lens (13 papers), Acne and Rosacea Treatments and Effects (12 papers) and Contact Dermatitis and Allergies (6 papers). Mark Holdbrook collaborates with scholars based in United States, Mexico and Germany. Mark Holdbrook's co-authors include Elizabeth Barrett‐Connor, Michael H. Criqui, Melissa A. Austin, Scott M. Grundy, Melville R. Klauber, John D. Turner, Joseph L. Witztum, Elizabeth Yeu, Robert B. Wallace and Gerardo Heiss and has published in prestigious journals such as American Journal of Epidemiology, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Mark Holdbrook

28 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Holdbrook United States 14 337 289 200 173 136 28 909
J. Lee Singapore 14 264 0.8× 100 0.3× 105 0.5× 116 0.7× 97 0.7× 17 775
B Costa Spain 15 489 1.5× 176 0.6× 74 0.4× 82 0.5× 61 0.4× 58 835
Rokhsareh Aghili Iran 17 287 0.9× 134 0.5× 59 0.3× 96 0.6× 33 0.2× 55 822
P R Hebert United States 12 86 0.3× 242 0.8× 381 1.9× 152 0.9× 18 0.1× 14 844
Surujpal Teelucksingh Trinidad and Tobago 15 187 0.6× 129 0.4× 32 0.2× 209 1.2× 79 0.6× 71 764
K.M. PRASANNA KUMAR India 12 711 2.1× 160 0.6× 154 0.8× 131 0.8× 10 0.1× 35 1.2k
Jing Bai China 13 57 0.2× 122 0.4× 136 0.7× 125 0.7× 51 0.4× 44 725
Flavia Lombardo Italy 15 346 1.0× 70 0.2× 116 0.6× 86 0.5× 18 0.1× 32 767
A. Samad Shera Pakistan 14 668 2.0× 145 0.5× 79 0.4× 78 0.5× 14 0.1× 19 979
Gijs W.D. Landman Netherlands 18 510 1.5× 94 0.3× 209 1.0× 224 1.3× 11 0.1× 68 1.4k

Countries citing papers authored by Mark Holdbrook

Since Specialization
Citations

This map shows the geographic impact of Mark Holdbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holdbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holdbrook more than expected).

Fields of papers citing papers by Mark Holdbrook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Holdbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holdbrook. The network helps show where Mark Holdbrook may publish in the future.

Co-authorship network of co-authors of Mark Holdbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Holdbrook. A scholar is included among the top collaborators of Mark Holdbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Holdbrook. Mark Holdbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnett, Melissa, William E. Whitson, Gregg J. Berdy, et al.. (2024). The impact of Demodex blepharitis on patient symptoms and daily life. Optometry and Vision Science. 101(3). 151–156. 5 indexed citations
2.
Paauw, James D., Joseph B. Ciolino, John Stirling Meyer, et al.. (2024). Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study. Cornea. 43(11). 1368–1374. 3 indexed citations
3.
Donnenfeld, Eric D., Paul Karpecki, Gregg J. Berdy, et al.. (2023). Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis. Ophthalmology. 130(10). 1015–1023. 25 indexed citations
4.
Holdbrook, Mark, et al.. (2022). Psychosocial Impact of Demodex Blepharitis. Clinical ophthalmology. Volume 16. 2979–2987. 21 indexed citations
7.
González-Salinas, Roberto, et al.. (2021). Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study. Investigative Ophthalmology & Visual Science. 62(8). 1332–1332. 2 indexed citations
8.
González-Salinas, Roberto, et al.. (2021). Collarette Elimination and Demodex Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25%. Journal of Ocular Pharmacology and Therapeutics. 37(8). 479–484. 11 indexed citations
9.
Yeu, Elizabeth, et al.. (2021). Clinical Manifestations of Demodex Blepharitis. 62(8). 1268–1268. 1 indexed citations
10.
González-Salinas, Roberto, Paul Karpecki, Elizabeth Yeu, et al.. (2021). Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial. Contact Lens and Anterior Eye. 45(4). 101492–101492. 24 indexed citations
11.
González-Salinas, Roberto, et al.. (2021). Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study. Journal of Ophthalmology. 2021. 1–7. 16 indexed citations
12.
Pattar, Guruprasad R., Gary Jerkins, David G. Evans, et al.. (2019). Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment. The Ocular Surface. 18(2). 249–257. 12 indexed citations
13.
Senchyna, Michelle, George W Ousler, Gary Jerkins, et al.. (2018). Effect of TrueTear™ on Dry Eye Symptoms During Exposure to a Controlled Adverse Environment. 59(9). 918–918. 2 indexed citations
14.
Franke, Manfred, et al.. (2017). Tear Total Lipid Concentration in Patients with Dry Eye Following Intranasal Neurostimulation. Investigative Ophthalmology & Visual Science. 58(8). 2693–2693. 9 indexed citations
15.
Watson, Michael A., Endri Angjeli, Manfred Franke, et al.. (2017). Effect of the Intranasal Tear Neurostimulator on Meibomian Glands. 58(8). 4387–4387. 5 indexed citations
16.
Watson, Michael A., Endri Angjeli, Manfred Franke, et al.. (2017). Quantitation of Tear Production by Tear Meniscus Height Following Acute Use of the Intranasal Tear Neurostimulator. 58(8). 2692–2692. 5 indexed citations
18.
Holdbrook, Mark, et al.. (2001). Two-year Corneal Endothelial Cell Assessment Following INTACS Implantation. Journal of Refractive Surgery. 17(5). 542–548. 18 indexed citations
19.
Criqui, Michael H., et al.. (1982). Multivariate correlates of adult blood pressures in nine North American populations: The lipid research clinics prevalence study. Preventive Medicine. 11(4). 391–402. 50 indexed citations
20.
Criqui, Michael H., Elizabeth Barrett‐Connor, Mark Holdbrook, Melissa A. Austin, & John D. Turner. (1980). Clustering of cardiovascular disease risk factors. Preventive Medicine. 9(4). 525–533. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026